Naringenin Inhibits the Formation of N ε ‐Carboxymethyllysine and Ameliorates Inflammation Induced by it in RAW 264.7 Cells
Biomedical Chromatography · 2026
DOI: 10.1002/bmc.70274 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2026. Verfasst von Lingxia Xu und 3 weiteren Autor:innen. Beteiligte Einrichtung: The National Pharmaceutical Engineering Center for Solid Preparation in Chinese Herbal Medicine, Jiangxi University of Chinese Medicine, Nanchang, Ch…. Hauptthemen laut MEDLINE: Flavanones, Lysine, Inflammation. Die Arbeit nennt 23 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Utilizing active ingredients to inhibit the formation of N ε ‐carboxymethyllysine (CML) and alleviate CML‐induced inflammation damage is crucial for treating diabetic nephropathy caused by CML. In the present study, we aimed to investigate the inhibitory effect and mechanism of naringenin (Nar) on the formation of CML and CML‐induced inflammation damage in RAW 264.7 cells. The results indicated that Nar could dose‐dependently inhibit the formation of CML in the system of L‐lysine and glyoxal (GO) by producing mono‐GO‐Nar, as evidenced by liquid chromatography coupled to tandem mass spectrometry (LC–MS/MS). Furthermore, CML‐induced inflammatory injury in RAW 264.7 cells was alleviated by Nar through the reduction of gene expression levels of TNF‐α and IL‐6. Further mechanistic studies suggested that Nar inhibited inflammatory injury via the AGEs/RAGE/NF‐κB pathway. In summary, our results initially demonstrated that Nar could inhibit the formation of CML and alleviate CML‐induced inflammation, which might represent a novel mechanism by which Nar combats chronic diseases where CML plays a significant role.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The National Pharmaceutical Engineering Center for Solid Preparation in Chinese Herbal Medicine, Jiangxi University of Chinese Medicine, Nanchang, China.
- Key Laboratory of Modern Preparation of Traditional Chinese Medicine, Ministry of Education, Jiangxi University of Chinese Medicine, Nanchang, China.
ORCID-Profile: Ting Tan
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Xu, L., Zhou, H., Tan, T., & Luo, Y. (2026). Naringenin Inhibits the Formation of N ε ‐Carboxymethyllysine and Ameliorates Inflammation Induced by it in RAW 264.7 Cells. Biomedical Chromatography. https://doi.org/10.1002/bmc.70274
Vancouver
Xu L, Zhou H, Tan T, Luo Y. Naringenin Inhibits the Formation of N ε ‐Carboxymethyllysine and Ameliorates Inflammation Induced by it in RAW 264.7 Cells. Biomedical Chromatography. 2026. doi:10.1002/bmc.70274
BibTeX
@article{Xu2026,
author = {Xu, Lingxia and Zhou, Huixian and Tan, Ting and Luo, Yun},
title = {Naringenin Inhibits the Formation of N ε ‐Carboxymethyllysine and Ameliorates Inflammation Induced by it in RAW 264.7 Cells},
journal = {Biomedical Chromatography},
year = {2026},
doi = {10.1002/bmc.70274}
}
EUVIMED